These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8490371)

  • 1. Filtering white cells from blood for transfusion.
    Smith R
    BMJ; 1993 Mar; 306(6881):810. PubMed ID: 8490371
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukocyte depletion for safe blood transfusion.
    Singh S; Kumar A
    Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technical note on a methodof leukophoresis by filtration].
    Latreille J; D'Autreuil P
    Union Med Can; 1976 Nov; 105(11):1711-3. PubMed ID: 982697
    [No Abstract]   [Full Text] [Related]  

  • 4. [Minutes of the 11th international symposium. Separation and transfusion of leukocytes. London - Royal Postgraduate Medical School October 11, 12, 13, 1976 (proceedings)].
    Rev Fr Transfus Immunohematol; 1976 Dec; 19(4):625-8. PubMed ID: 1021880
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of two types of leukocyte removal filters on transfusion dependent thalassaemics.
    Jamal R; Mazeni NR; Hussin H
    Malays J Pathol; 2000 Dec; 22(2):79-83. PubMed ID: 16329539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of white blood cell retention by white blood cell removal filters.
    Sivakumaran M
    Transfusion; 2004 Sep; 44(9):1271-2. PubMed ID: 15318847
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuous blood cell separation by hydrophoretic filtration.
    Choi S; Song S; Choi C; Park JK
    Lab Chip; 2007 Nov; 7(11):1532-8. PubMed ID: 17960282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing hemoglobin oxygen saturation levels in sickle trait donor whole blood prevents hemoglobin S polymerization and allows effective white blood cell reduction by filtration.
    Stroncek DF; Byrne KM; Noguchi CT; Schechter AN; Leitman SF
    Transfusion; 2004 Sep; 44(9):1293-9. PubMed ID: 15318851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filtration leukopheresis for separation and concentration of transfusable amounts of normal human granulocytes.
    Djerassi I; Kim JS; Mitrakul C; Suvansri U; Ciesielka W
    J Med; 1970; 1(6):358-64. PubMed ID: 5286503
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement activation in prestorage leucocyte-filtered plasma.
    Hyllner M; Tylman M; Bengtson JP; Rydberg L; Bengtsson A
    Transfus Med; 2004 Feb; 14(1):45-52. PubMed ID: 15043593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease.
    Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P
    Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White particulate matter found in blood collection bags consist of platelets and leukocytes.
    Rentas FJ; Macdonald VW; Rothwell SW; McFaul SJ; Asher LV; Kennedy AM; Hmel PJ; Meledandri CJ; Salata JM; Harman RW; Reid TJ
    Transfusion; 2004 Jul; 44(7):959-66. PubMed ID: 15225233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How free of residual cells and cell antigens is human blood plasma? A comparison of different production methods of human blood plasma and the risk of the products for patients.
    Wurm K; Rummler S; Barz D
    Transfus Apher Sci; 2008 Apr; 38(2):149-57. PubMed ID: 18348910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage.
    Arnold DM; Molinaro G; Warkentin TE; DiTomasso J; Webert KE; Davis I; Lesiuk L; Dunn G; Heddle NM; Adam A; Blajchman MA
    Transfusion; 2004 Sep; 44(9):1361-6. PubMed ID: 15318862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanisms of immunomodulation after transfusion of allogeneic and autologous red cell concentrate].
    Innerhofer P; Kühbacher G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Nov; 37(11):681-4. PubMed ID: 12404147
    [No Abstract]   [Full Text] [Related]  

  • 17. Leucocyte depleted blood: an appraisal of available techniques.
    Hughes AS; Brozović B
    Br J Haematol; 1982 Mar; 50(3):381-6. PubMed ID: 7039660
    [No Abstract]   [Full Text] [Related]  

  • 18. Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion.
    Glenngård AH; Persson U; Söderman C
    Transfus Med; 2005 Aug; 15(4):295-306. PubMed ID: 16101807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of blood transfusion devices.
    Ciavarella D; Snyder E
    Transfus Med Rev; 1988 Jun; 2(2):95-111. PubMed ID: 2980083
    [No Abstract]   [Full Text] [Related]  

  • 20. [The efficiency of a new porous type leukocyte removal filter for red cell blood components, Terumo Imuguard III-RC, in the rapid transfusion conditions].
    Kajiyama S; Nakao M; Kawaguchi R; Nakatani K; Okada Y; Hazama K; Unetani H; Hanaki C
    Masui; 1997 Jun; 46(6):855-9. PubMed ID: 9223894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.